2007-March Archives by Thread
Starting: Thu Mar 1 05:09:23 2007
Ending: Sat Mar 31 19:44:29 2007
Messages: 198
- [Ip-health] Mashelkar Plagiarism Controversy-2
Lawrence Liang
- [Ip-health] Bridges Weekly: BREAKTHROUGH ON WIPO DEVELOPMENT AGENDA
Thiru Balasubramaniam
- [Ip-health] Bangladesh submission to WHO IGWG on Public Health, Innovation and Intellectual Property Rights
James Packard Love
- [Ip-health] Caution over Swiss Firm Patenting Cancer-fighting Drug
Joana Ramos
- [Ip-health] Submission to WHO/IGWG by Bolivia, in Spanish
James Packard Love
- [Ip-health] English translation: Submission to WHO/IGWG by Bolivia
James Packard Love
- [Ip-health] Email alert: March issue of the WHO Bulletin
bulletin
- [Ip-health] Brazil submission to WHO/IGWG
James Packard Love
- [Ip-health] FDA warns drugmakers over unapproved headache drugs
Joana Ramos
- [Ip-health] MSF study on second-line AIDS treatment in resource poor settings: But
Access to newer medicines remains an alarming proglem
Buddhima Lokuge
- [Ip-health] Launch of new non-patented Low-Cost Antimalaria medicine
Buddhima Lokuge
- [Ip-health] =?Windows-1252?Q?Mint_India:_There=92s_a_lesson_to_be_learnt_here=2C_says?=
=?Windows-1252?Q?_Mashelkar?=
Achal Prabhala
- [Ip-health] IPN et. al.: UN, =?windows-1252?Q?governments=92_policies_ca?=
=?windows-1252?Q?use_avoidable_disease_and_suffering?=
robert weissman
- [Ip-health] Changes in US patent review process
Rohit Malpani
- [Ip-health] Novartis letter to the MEPs requesting them to not sign the Written
Declaration. In the Declaration MEPs call Novartis to withdraw the case
and call the EU Commission and EU Council to take a similar position
Alexandra HEUMBER
- [Ip-health] Compulsory Licences could save 1Bln baht
Sarah Rimmington
- [Ip-health] (no subject)
chan park
- [Ip-health] possible legislation to raise standards for US patents
Benjamin Krohmal
- [Ip-health] Dates for June WIPO PCDA and SCCR meetings
Thiru Balasubramaniam
- [Ip-health] Wall Street Journal: Global Health, China's Pride On Line in Malaria Clash
Thiru Balasubramaniam
- [Ip-health] Novartis Hearing Update, 6.3.07
chan park
- [Ip-health] Concern about benefits of RED aids campaign
Michelle Childs
- [Ip-health] Vasella questioned at the General Meeting in Basel about Novartislegal
action against India
Alexandra HEUMBER
- [Ip-health] Washington Times Op-ed: The Innovation Agenda
Sarah Rimmington
- [Ip-health] Compulsory licensing of patents: Communique issued by the French Minister for Research, Paris 07.09.2001
James Packard Love
- [Ip-health] KEI Brown Bag: Hanson on Grants vs. Prizes for Innovation
Benjamin Krohmal
- [Ip-health] Glivec raises concerns on post-marketing study (factiva)]
Joana Ramos
- [Ip-health] Celgene, Novartis File Suit to Block Generic Ritalin
Joana Ramos
- [Ip-health] Combivir patent rejected in China
James ARKINSTALL
- [Ip-health] Wall Street Journal Editorial: Bangkok's Drug War Goes Global
Thiru Balasubramaniam
- [Ip-health] Novartis Image Shaken with GIPAP Scandal
Joana Ramos
- [Ip-health] Wall Street Journal: Novartis Angers Critics in India
Thiru Balasubramaniam
- [Ip-health] [Fwd: [NHeLP] Job Opening: Staff Attorney at PAL
Joana Ramos
- [Ip-health] The Hindu: Dilip Shah of IPA on Mashelkar Report
chan park
- [Ip-health] George Washington University's CIEC's "Partners"
James Packard Love
- [Ip-health] Lisa Conte in Huffington Post on Novartis Case
Mike Palmedo
- [Ip-health] Bridges Weekly: BANGLADESH AND BOLIVIA CALL FOR EXTENSION OF WHO WORKING GROUP ON PUBLIC HEALTH, INNOVATION AND INTELLECTUAL PROPERTY
Thiru Balasubramaniam
- [Ip-health] Glivec Controversy : Spanner In The Works
Joana Ramos
- [Ip-health] Novartis's Rebuttal: Glivec Controversy: Spanner In The Works
Joana Ramos
- [Ip-health] IP-Watch (Monthly Edition): WIPO Development Agenda Negotiation Surges Ahead
Thiru Balasubramaniam
- [Ip-health] Times of India Editorial, Generic drugs only hope for many AIDS, Cancer Patients
msfh-india-medco-assist
- [Ip-health] patent save lifes - Brazilian Directof of corporate Affairs of Novartis in the Gazeta Mercatil - Brazil
MSF Michel Lotrowska
- [Ip-health] Richard Rockefeller, Times of India Editorial published today
Alexandra HEUMBER
- [Ip-health] Merck's Murky Dealings: HPV Vaccine Lobby Backfires
Riaz K Tayob
- [Ip-health] Mashelkar committee report
Graham Dutfield
- [Ip-health] Pepfar, Generics, Price
robert weissman
- [Ip-health] Stiglitz on medical innovation prizes
Benjamin Krohmal
- [Ip-health] Manufacturing costs for second line AIDS drugs
James Packard Love
- [Ip-health] PROMINENT INNOVATION PRIZES AND REWARD PROGRAMS
James Packard Love
- [Ip-health] Thailand, Wall Street Journal and Media Prostitution
Daya Shanker
- [Ip-health] [UAEM] Universities Release Best Practices for Licensing "In the Public Interest"
Robynn Sturm
- [Ip-health] Who is SIGWatch and where does it get its info on patents cases?
Joana Ramos
- [Ip-health] Recent examples of the use of compulsory licenses on patents
James Packard Love
- [Ip-health] The economist on Prizes for Innovation
Ellen 't Hoen
- [Ip-health] About Mr Myc Riggulsford
James Packard Love
- [Ip-health] Statement in the British Parliament on Thailand CL
James Packard Love
- [Ip-health] $250,000 Open Architecture Prize prize for developing world.
James Love
- [Ip-health] REMINDER: KEI Brown Bag this Friday
Benjamin Krohmal
- [Ip-health] KEI Brownbag this Thursday: Sakiko Fukuda-Parr on The Gene Revolution
Malini Aisola
- [Ip-health] Letter from 12 U.S. Congress members to USTR Representative Susan Schwab: US Trade Policies Restrict Access to Life Saving Medicines
Thiru Balasubramaniam
- [Ip-health] Ronald A. Cass in the Wall Street Journal: Thai Patent Turmoil
Thiru Balasubramaniam
- [Ip-health] IP-Watch: Thailand Presents Report On Compulsory Licensing Experience
Mike Palmedo
- [Ip-health] Abbott won't launch new drugs in Thailand
Benjamin Krohmal
- [Ip-health] Frontline: Cleaning up after Mashelkar - Praful Bidwai
Achal Prabhala
- [Ip-health] Frontline: Batting for MNCs - Dinesh Abrol
Achal Prabhala
- [Ip-health] Frontline: Against Monopoly - Yusuf Hamied
Achal Prabhala
- [Ip-health] ZeeNews: Mashelkar can resubmit report - Govt
Achal Prabhala
- [Ip-health] Highlights from the European Union's 17 May 2007 regulation on compulsory licensing
James Packard Love
- [Ip-health] Re: [aidsdrugs] Abbott Abusive Registration Practices
B.Baker@neu.edu
- [Ip-health] Colombian study on impact of FTA on medicines
Mike Palmedo
- [Ip-health] WSJ: "Why Generic Doesn't Always Mean Cheap"
Benjamin Krohmal
- [Ip-health] Letters to Wall Street Journal from KEI, IFPMA and Oxfam on "Bangkok's Drug War Goes Global" editorial
Thiru Balasubramaniam
- [Ip-health] Wall Street Journal editorial: The Thai Flu
Thiru Balasubramaniam
- [Ip-health] MSF's response to WSJ Editorial on March 7, 2007
Buddhima Lokuge
- [Ip-health] Abbott excessive pricing of AIDS drug investigation likely in US
Buddhima Lokuge
- [Ip-health] PIJIP Analysis of Thai Law on Government Use Licenses
Mike Palmedo
- [Ip-health] "Mandelson keeps mum on Indian drugs case"
Alexandra HEUMBER
- [Ip-health] Friday Capitol Hill Briefing on Thailand Situation
Benjamin Krohmal
- [Ip-health] Thailand briefing details
Benjamin Krohmal
- [Ip-health] Business Standard: Mashelkar gets time to purge `follies`
Achal Prabhala
- [Ip-health] The Hindu: Expert group to review Mashelkar report
Achal Prabhala
- [Ip-health] comments from Abbott, Thailand
Benjamin Krohmal
- [Ip-health] March 8, 2007 Geneva Q&A Session on Thai White Paper
James Packard Love
- [Ip-health] Le Temps (Swiss newspaper): Abbott ne laisse pas intimider en Thailande
Thiru Balasubramaniam
- [Ip-health] Bridges Weekly: AGREEMENT ELUDES US AND KOREA IN FTA TALKS, DESPITE PROGRESS
Thiru Balasubramaniam
- [Ip-health] Bridges Weekly: THAI GOVERNMENT EXPLAINS COMPULSORY LICENCE POLICY ON PATENTED DRUGS
Thiru Balasubramaniam
- [Ip-health] REMINDER: KEI Brownbag TODAY on The Gene Revolution
Malini Aisola
- [Ip-health] Abbott - A New Low in the Pharma Drug Wars
B.Baker@neu.edu
- [Ip-health] Legal Analysis of Patent Breaking/Compulsory Licensing in the Face of Public Health Crisis
Chris Nidel
- [Ip-health] MSF Denounces Abbott's Move to Withhold Medicines From People in Thailand
Benjamin Krohmal
- [Ip-health] Bayer supports Abbott's move in Thailand
Benjamin Krohmal
- [Ip-health] France - GSK found guilty of predatory pricing to hinder generic entry
James Love
- [Ip-health] Times of India: Interest Group Capture - Sudhir Krishnaswamy
Achal Prabhala
- [Ip-health] The Hindu: Time for international action on patents
Achal Prabhala
- [Ip-health] Thailand's government use licences
Peter Drahos
- [Ip-health] Times of India: Mashelkar panel member in favour of fresh 'conclusions'
Achal Prabhala
- [Ip-health] TRIPS, Mashelkar and Administrative Perversion
Daya Shanker
- [Ip-health] EPW: Is Plagiarism the only problem with the Mashelkar report?
Achal Prabhala
- [Ip-health] SciDev.Net editorial: time for action on patents
James ARKINSTALL
- [Ip-health] US Commerce Secty Gutierrez Criticizes Thai CL
robert weissman
- [Ip-health] The Hindu: Mashelkar quits patents expert panel
chan park
- [Ip-health] INTELLECTUAL PROPERTY AND ACCESS TO TREATMENT: HOW CAN PATENT LAW WORK FOR PUBLIC HEALTH?
Caroline Gallant
- [Ip-health] Pre G8 UK Parliament Event with Hilary Benn and Day of Action 20th March
Michelle Childs
- [Ip-health] Mashelkar resigns
kannamma raman
- [Ip-health] LA Times: Setting a Price for Putting Off Death
Mike Palmedo
- [Ip-health] US law on govt. use of patents
Benjamin Krohmal
- [Ip-health] US Supreme Court may hear pharma antitrust case
Benjamin Krohmal
- [Ip-health] Hindu interviews on Novartis Case
Ragavan, Srividhya
- [Ip-health] The Hill: House Democrats scrutinize price tag of AIDS drug
Mike Palmedo
- [Ip-health] Setting a price for putting off death: A few more months of life may not be worth the costs of new cancer therapies, some argue.
James Love
- [Ip-health] For Alexion, Third Time's The Charm...new drug, Soliris, to treat
a rare blood disorder called paroxysmal nocturnal hemoglobinuria (PNH).
Joana Ramos
- [Ip-health] Activists push for global boycott
Kannikar KIJTIWATCHAKUL
- [Ip-health] [Fwd: Litigation & Enforement in the Biotech and Pharmaceutical Industry
Conference - One Month Left to Register]
Joana Ramos
- [Ip-health] AP: Thai Health Groups Urge Abbott Boycott
Thiru Balasubramaniam
- [Ip-health] Reuters: Thailand Talking with Drug Firms - U.S. Chamber
Thiru Balasubramaniam
- [Ip-health] IPS: US Pharma Giant Faces Public Boycott
Thiru Balasubramaniam
- [Ip-health] Mike's notes on Korea meeting
Sean Flynn
- [Ip-health] PhRMA testimony at House Ways and Means Subcommittee on Trade
Mike Palmedo
- [Ip-health] Doctors' Ties to Drug Makers Are Put on Close View
James Packard Love
- [Ip-health] Compulsory licensing of patents under ebay decision
James Packard Love
- [Ip-health] University of Arkansas immunity from patent infringment
James Packard Love
- [Ip-health] Compulsory licensing of patents under ebay decision
Luis Villarroel Villalon
- [Ip-health] Petition: support public access to medical research
Benjamin Krohmal
- [Ip-health] Compulsory licensing of patents under ebay
decision
Anne St. Martin
- [Ip-health] Korea hearing and health: Rep. Blumenauer's tobacco questions,
pharma
Ellen Shaffer
- [Ip-health] State impacts of Korea FTA
Sean Flynn
- [Ip-health] US Chamber of Commerce on Thailand's IP
Mike Palmedo
- [Ip-health] TNA: EC "concerned" over Thai CLs
Khalil Elouardighi - Act Up-Paris
- [Ip-health] 'All costs, no benefits: How TRIPS-plus intellectual property rules in the
US-Jordan FTA affect access to medicines'.
Elizabeth Wabuge
- [Ip-health] 2007 Accelerating Anticancer Agent Development and Validation Workshop
Joana Ramos
- [Ip-health] New Oxfam briefing paper on the costs and benefits of the US - Jordan free trade agreement
Rohit Malpani
- [Ip-health] Editorial: Putting meaning back into TRIPS
Sarah Rimmington
- [Ip-health] Who will be sued next? - Scrip editorial
Ellen T HOEN
- [Ip-health] Indian Express: Terra pharma
Achal Prabhala
- [Ip-health] Amazon promotes essential facilities, reasonable royalty rules
robert weissman
- [Ip-health] Empirical Paper on ARVs in Sub-Saharan Africa
Colleen Chien
- [Ip-health] Investors criticize Abbott
Benjamin Krohmal
- [Ip-health] Notes from D.C. Thailand Breifing
ben.krohmal@keionline.org
- [Ip-health] Congress Leaders to USTR: Drop TRIPS-Plus in FTAs
Ellen Shaffer
- [Ip-health] Lancet: WHO and Abbott in Thailand
Kannikar KIJTIWATCHAKUL
- [Ip-health] U.S. Pres. candidate on Thailand & global framework
Benjamin Krohmal
- [Ip-health] Abbott's anticompetitive practices in Thailand
Sean Flynn
- [Ip-health] MSF. Abbott should reconsider its unacceptable decision
Buddhima Lokuge
- [Ip-health] Drug firms' funding of advocates often escapes government scrutiny
Joana Ramos
- [Ip-health] Abbott criticized; silent on Thailand
ben.krohmal@keionline.org
- [Ip-health] Economic Times: DIPP Opposes Mashelkar Suggestions
chan park
- [Ip-health] A US court judgment that is relevant to Novartis case
Joana Ramos
- [Ip-health] Fwd: [A2k] massive attack on Brazil's IPR policies
Michelle Childs
- [Ip-health] SUNS: Drug-resistant TB treatment barely succeeds
Sangeeta
- [Ip-health] Novartis Update, 26.3.07
chan park
- [Ip-health] The Big Idea: Prizes to Stimulate R&D for New Medicines
James Packard Love
- [Ip-health] Wall Street journal: Poor Countries Seek Pact On Avian-Flu Vaccines
Thiru Balasubramaniam
- [Ip-health] PUBPAT News: PUBPAT Takes On Key HIV/AIDS Drug Patents
Public Patent Foundation
- [Ip-health] Dean Baker: Thailand takes the lead in promoting free trade
Dan Beeton
- [Ip-health] France gives public support to Thai CLs
Khalil Elouardighi - Act Up-Paris
- [Ip-health] Wall Street Journal: Democrats' New Trade Agenda May Stall Broader Bush Goals
Thiru Balasubramaniam
- [Ip-health] Italy issues compulsory license on Merck drug
James Packard Love
- [Ip-health] Novartis Update, 27.3.07
chan park
- [Ip-health] Wall Street Journal: Indonesia to Resume Sharing Bird-Flu Virus Samples
Thiru Balasubramaniam
- [Ip-health] Sanofi trying a deal in Thailand
Judit Rius Sanjuan
- [Ip-health] Ways & Means statement
Ellen Shaffer
- [Ip-health] Shamnad Basheer on India's New Patent Regime
Sean Flynn
- [Ip-health] now online - Ways & Means statement
Ellen Shaffer
- [Ip-health] Novartis Update, 28.3.07
chan park
- [Ip-health] LeMonde on Thai CL, France, Abbott
Khalil Elouardighi - Act Up-Paris
- [Ip-health] compulsory license boosts Abbott profits
Benjamin Krohmal
- [Ip-health] Philippines: U.S. Norvasc ruling supports IP reform
Benjamin Krohmal
- [Ip-health] Nature: Plagiarised report on patent laws shames Indian scientists
Achal Prabhala
- [Ip-health] Novartis Update, 29.03.07
chan park
- [Ip-health] Thailand/New business model for innovation and Thai Govt/Pharma talks
Sarah Rimmington
- [Ip-health] Democratic Urged USTR to Change Course in US-Korea FTA Negotiations
heeseob nam
- [Ip-health] Financial Times: Corners are cut in order to bring drugs to Africa
Thiru Balasubramaniam
- [Ip-health] Novartis Update, 30.03.07
chan park
- [Ip-health] Washington Post Editorial: A Dose of Innovation
Thiru Balasubramaniam
- [Ip-health] A Drug Deal Gone Bad - by Sean Flynn and Sharon Treat in Tompaine.com
Mike Palmedo
- [Ip-health] More on the Italian compulsory license for finasteride
James Packard Love
- [Ip-health] VBB on Merck Italian CL
James Packard Love
- [Ip-health] Fwd:: 60 Minutes Takes on the Drug Industry: Sunday, April 1st (No
Joke)]
Joana Ramos
- [Ip-health] Georges and Bay on "the Italian Case"
James Packard Love
- [Ip-health] Two other Italian CLs, GSK's migraine drug, and Merck's broad spectrum antibiotic
James Packard Love
- [Ip-health] It: official press release on finasteride CL, (also mentions the two previous CL cases)
James Packard Love
- [Ip-health] Reuters: Korea FTA Talks Stumble at Last Minute
Mike Palmedo
- [Ip-health] Fwd: [G & H] CPATH: Korea, meds, tobacco
Ellen Shaffer
- [Ip-health] Newsweek: Thailand's New Drug War
ben.krohmal@keionline.org
Last message date:
Sat Mar 31 19:44:29 2007
Archived on: Sat Mar 31 19:44:30 2007
This archive was generated by
Pipermail 0.05 (Mailman edition).